|By PR Newswire||
|December 9, 2013 04:44 PM EST||
TARZANA, Calif., Dec. 9, 2013 /PRNewswire-iReach/ -- Dr. Afshine Ash Emrani, MD, FACC of Los Angeles Heart Specialists has been well recognized amongst his peers as a leading physician in the field of preventative care. He has practiced in the Los Angeles area for the past fifteen years and has been recognized as a teacher and mentor to students as well as Assistant Clinical Professor, U.C.L.A. at the David Geffen School of Medicine. Dr. Emrani performs DEXA bone densitometry in his office as part of his comprehensive fracture risk reduction program. Osteoporosis is a leading cause of morbidity and mortality amongst the aging. As a result of the excellence in care achieved by Dr. Emrani, Amgen has collaborated with his clinic to make Los Angeles Heart Specialists an official Prolia administration site.Prolia® (denosumab) is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or areintolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, Prolia® reduces the incidence of vertebral, nonvertebral, and hip fractures. Prolia® is also indicated for treatment to increase bone mass in men with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.
For more details please visit
Media Contact: Afshine Emrani MD FACC, Los Angeles Heart Specialists, 818-9964100, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Los Angeles Heart Specialists